Oncolin Therapeutics, Inc. (OTCBB: OCOL)
Oncolin Therapeutics, Inc. (OTCBB: OCOL) – Tuesday’s shares closed down 10% to $0.27. 17,175 shares were traded. Oncolin Therapeutics, Inc. announced May 5th that Dr Randall K. Johnson agreed to join the Scientific Advisory Board of the company joining a growing number of illustrious oncologists and cancer drug developers. Dr Johnson began his career as section Head of the Experimental Chemotherapy at the National Cancer Institute. Most of his accomplishments occurred over more than twenty years at Glaxo SmithKline where he held various senior positions in oncology culminating in Oncology Group Director. Among the many accomplishments during his tenure was the development of Topotecan which continues to be a major drug used in cancer therapy today. For the past five years Dr Johnson has consulted for numerous drug and biotech companies and is a member of many Scientific Advisory Boards and clinical advisory Boards for oncology based companies.
Oncolin Therapeutics, Inc. is a biopharmaceutical company focused on developing drugs which interfere with the key mechanisms of cancer tumor development. The company engages in the discovery, development and commercialization of novel selective anticancer therapies. The company has a lead drug for brain cancer in preclinical development licensed from the MD Anderson Cancer Center. Oncolin is focused on the development of this drug to clinical development with an IND scheduled to be filed in approximately 18 months [ Investigational New Drug (application to the FDA) ]. The company also has a robust pipeline of oncology research programs that are mainly funded by Federal grants.
ALL Fuels & Energy Company (OTCBB: AFSE)
ALL Fuels & Energy Company (OTCBB: AFSE) – Tuesday’s shares rose 33.33% to $0.48. The volume was 80,910. ALL Fuels & Energy (AFSE) announced May 5th that its new subsidiary, AFSE Enzyme, signed a letter of intent with a research and development institution that would host the company’s “super” enzyme research and development. With the letter of intent process completed, AFSE Enzyme will begin the process of negotiating licensing and marketing agreements, which is expected to be completed within 90 days. “The selection of this research institution has been running on a parallel track with our ongoing testing of our first super enzyme’s capacity for boosting production of corn and cellulosic ethanol,” said Dean Sukowatey, AFSE President. �We remain excited about commercializing this super enzyme that could result in a possible production costs savings of up to 50%.�
ALL Fuels & Energy Company is a development-stage ethanol company organized to operate as an ethanol producer, focusing primarily on the production and sale of ethanol and its co-products. To date, AFSE has: obtained $2.3 million in private equity funding; purchased 150 acres on which to build its proposed ethanol production facility in Manchester, Iowa; signed a five-plant engineering and design agreement; engaged Natural Resources Group to handle water-related environmental matters relating to the proposed Manchester ethanol production facility; engaged Yaggy-Colby to handle air-related environmental matters relating to the proposed Manchester ethanol production facility; and investigated and become involved in the potential acquisition of one or more existing ethanol production facilities.
Essential Innovations Technology Corp. (OTCBB: ESIV)
Essential Innovations Technology Corp. (OTCBB: ESIV) – Tuesday’s shares stayed even at $0.12. 97,807 was the volume. Essential Innovations Technology announced May 5th that Mr. Stephen Clevett, President & CEO of Optimira Energy Canada, Ltd. (”Optimira”), officially joined the ESIV Board of Directors. “With the inclusion of Mr. Stephen Clevett to the ESIV Board of Directors, we continue to make great strides towards our goal of attracting to the Company external skills and guidance from individuals with powerful credentials and proven industry prowess in their particular or chosen fields of expertise. Mr. Clevett has extensive background in the financing, structuring and operation requisites that apply to traditional conventional ESCO projects. He now brings this skill set to ESIV and gives our Company the benefit of an inherent advantage when we enter into negotiations and ultimately look to facilitate Geoexchange ESCO projects. Mr. Clevett’s direct ESCO experience combined with his business and finance background, makes him a wonderful complement to the last Board addition we had made in latter 2006, of Mr. Salvador Diaz-Verson, the former President/CIO of AFLAC and founder of Miramar Securities a registered broker/dealer in Atlanta, Georgia. Mr. Diaz-Verson had initially brought to the ESIV Board of Directors a history of truly top-level world-class finance and capital market knowledge, and with the formal addition of Mr. Clevett now complete we are nearing our final objective of having a totally independent, superlative Board membership that can help our management team to enhance and bring further credibility to our current and future business. Mr. Clevett joining our team is representative of our successful pursuit of specific endeavors that will help to enhance our Board and ultimately that will help us to flourish and to achieve our long-term growth plan for the Company,” commented Jason McDiarmid, President/CEO of ESIV.
Essential Innovations Technology Corp. provides cutting-edge Geoexchange solutions for residential, commercial and industrial applications as both a Geoexchange energy service company and as a manufacturer of proprietary geothermal heat pump technology. Essential Innovations manufactures and distributes its proprietary cutting edge GeoExchange System, the “EI Elemental Series”, in Vancouver, Canada. The EI Elemental family of products are high efficiency, eco-friendly comfort systems providing heating, cooling, dehumidification as well as domestic hot water production for residential, commercial and industrial applications.
Euoko Group Inc. (OTCBB: EUOK)Euoko Group Inc. (OTCBB: EUOK) – Tuesday’s shares stayed even at $1.81. No shares were traded. Kris Gupta, CFA for Equity Stock Analysis, issued a research report regarding the future potential of Euoko Group. The full report is available at http://www.equitystockanalysis.com. In the report, Kris Gupta writes, �Euoko Group Inc. is engaged in the business of development, marketing and distribution of luxury and mainstream skin treatments. It offers twenty-four luxury skin treatment products categorized into five collections: R-Series for enhancing skin radiance, Y-Series for targeting lines and wrinkles, A-Series for blemish-prone skin, P-Series for diverse environmental protection and W-Series for correcting pigmentation problems.
Euoko Group Inc. owns premium brands that develop, market and distribute scientifically-advanced skin treatments, including the brand, Euoko. Euoko’s current portfolio consists of 24 products spanning five treatment collections that target aging, dull skin tones, skin protection, uneven pigmentation and blemishes. This product line offers comprehensive solutions to such skin concerns as wrinkles, fine lines, under-eye dark circles, dark spots, acne, oxidation, environmental exposure and skin fatigue. Combined with innovative products for basic daily cleansing and facial priming, Euoko offers a complete line of synergistic formulations that target the most demanding luxury consumer. Euoko’s well-appointed, understated primary and secondary packaging communicates innovation, science and modern sophistication, while reflecting the prestige positioning of the portfolio. Euoko sells its product line through premium distribution channels and is represented in more than fifteen countries and territories worldwide. Retail partners of the brand include such premium department stores as Bergdorf Goodman in New York City (USA), Printemps in Paris (France) and La Rinascente in Milan (Italy). Euoko’s products are also sold globally through the company’s internally-operated, multicurrency, multilingual website.
